Comparison of the survival implications of tumour-associated versus cancer-testis antigen expression in acute myeloid leukaemia [2]

British Journal of Haematology

Volumn 136, Issue 3, 2007, Pages 510-512

  Guinn, Barbara Ann ^a   Tobal, Khalid ^a   Mills, Ken I ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Acute leukaemia; Array; Immunotherapy; Myeloid leukaemia; Tumour antigens

Indexed keywords

BIOLOGICAL MARKER; CANCER TESTIS ANTIGEN; LEUKEMIA ANTIGEN; TUMOR ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; CANCER REGRESSION; CANCER SURVIVAL; CELL LINEAGE; CORRELATION ANALYSIS; DNA MICROARRAY; HUMAN; LETTER; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; WORLD HEALTH ORGANIZATION;

ACUTE DISEASE; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; HUMANS; LEUKEMIA, MYELOID; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 33845971509     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06454.x     Document Type: Letter

References (8)

1. Adams, S.P., Sahota, S.S., Mijovic, A., Czepulkowski, B., Padua, R.A., Mufti, G.J. & Guinn, B.A. (2002) Frequent expression of HAGE in presentation chronic myeloid leukaemias. Leukemia, 16, 2238-2242.
2. Greiner, J., Ringhoffer, M., Taniguchi, M., Hauser, T., Schmitt, A., Dohner, H. & Schmitt, M. (2003) Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia. International Journal of Cancer, 106, 224-231.
3. Greiner, J., Schmitt, M., Li, L., Giannopoulos, K., Bosch, K., Schmitt, A., Dohner, K., Schlenk, R.F., Pollack, J.R., Dohner, H. & Bullinger, L. (2006) Expression of tumor-associated antigens in acute myeloid leukemia: implications for specific immunotherapeutic approaches. Blood, doi: 10.1182/blood-2006-01-023127.
4. Grimwade, D., Walker, H., Oliver, F., Wheatley, K., Harrison, C., Harrison, G., Rees, J., Hann, I., Stevens, R., Burnett, A. & Goldstone, A. (1998) The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood, 92, 2322-2333.
5. Guinn, B.A., Bland, E.A., Lodi, U., Liggins, A.P., Tobal, K., Petters, S., Wells, J.W., Banham, A.H. & Mufti, G.J. (2005) Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia. Biochemical and Biophysical Research Communications, 335, 1293-1304.
6. Guinn, B.A., Gilkes, A.F., Mufti, G.J., Burnett, A.K. & Mills, K.I. (2006) The tumour antigens RAGE-1 and MGEA6 are expressed more frequently in the less lineage restricted subgroups of presentation acute myeloid leukaemia. British Journal of Haematology, 134, 238-239.
7. Inoue, K., Sugiyama, H., Ogawa, H., Nakagawa, M., Yamagami, T., Miwa, H., Kita, K., Hiraoka, A., Masaoka, T. & Nasu, K. (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood, 84, 3071-3079.
8. Matsushita, M., Ikeda, H., Kizaki, M., Okamoto, S., Ogasawara, M., Ikeda, Y. & Kawakami, Y. (2001) Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia. British Journal of Haematology, 112, 916-926.